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Abstract 
Background: Meningitis with a negative cerebrospinal (CSF) Gram stain represents a diagnostic and therapeutic 
challenge. The purpose of our study was to evaluate the performance of the BioFire FilmArray® Meningitis/Encephali-
tis (FA ME) panel in patients presenting with community-acquired meningitis with a negative Gram stain.
Methods: CSF from 48 patients with community-acquired meningitis with a negative Gram stain admitted to four 
hospitals in Houston, TX underwent additional testing by the FA ME. FA ME results were compared to results obtained 
as part of routine evaluation.
Results: The panel detected pathogens not previously identified in 11 (22.9 %) of 48, but did not detect pathogens 
identified by standard technique (West Nile virus, Histoplasma) in 5 (15.2 %) patients.
Conclusions: Rapid testing for the most common pathogens causing meningitis will aid in the diagnosis and treat-
ment of patients with meningitis.
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Background
Meningitis with a negative cerebrospinal fluid (CSF) 
Gram stain represents a diagnostic and therapeutic chal-
lenge, as the majority of the causative organisms are 
unknown [1]. Clinicians on the front lines are faced with 
multiple diagnostic dilemmas in an effort to ensure bac-
terial or other treatable infections are not missed. A vari-
ety of strategies have been employed to assist physicians 
including the use of advanced molecular techniques. 
Such advanced strategies are not widely accessible, tan-
dem agent testing requires lengthy turn-around time at a 
distal reference laboratory and definitive results are com-
plicated by specimen contamination and limited available 
volume [2]. Identifying the specific etiology of meningitis 
with a negative CSF Gram stain has important clinical, 
public health and antibiotic use implications. We evalu-
ated the performance of the BioFire FilmArray Menin-
gitis/Encephalitis (FA ME) panel in patients presenting 
with community-acquired meningitis with a negative 
Gram stain. CSF samples were obtained from patients 
admitted to four hospitals in Houston, TX comparing the 
BioFire FA to routine laboratory evaluation.
Methods
Patients admitted between November 2008 and March 
2014 with community-acquired meningitis or encepha-
litis (fever, headache, vomiting, photophobia, stiff neck, 
focal neurological symptoms), CSF cell count  >5 cells/
mm [3] and a negative CSF Gram stain were eligible. 
Residual patient CSF underwent additional testing by a 
research use only version of the FilmArray Meningitis/
Encephalitis panel (FA ME, BioFire Diagnostics, LLC) 
according to the manufacturer’s instructions [3]. Briefly 
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residual CSF sample was combined with FilmArray Sam-
ple Buffer in a 1:4 ratio and then injected into a FilmArray 
pouch. The panel requires 200 µL of CSF and simultane-
ously tests for six bacteria (S. pneumoniae, N. menin-
gitidis, S. agalactiae, H. influenzae, L. monocytogenes, 
E. coli K1), eight viruses [Herpes simplex types (HSV) 1 
and 2, Human herpesvirus 6, Cytomegalovirus, Epstein-
Barr virus (EBV), Enterovirus, Parechovirus, Varicella 
zoster virus (VZV)] and two fungi (Cryptococcus gat-
tii/neoformans). Two minutes of user hands-on time 
are required and comprehensive results are returned in 
approximately 1 h. The University of Texas Institutional 
Review Board approved the study and results were not 
used in patient management.
Results
Of 149 patients with community-acquired meningitis, 48 
(32.2  %) had residual CSF (38 adults, 10 children  <  age 
18) available for FA ME testing. Median age of patients 
was 38.3  months (range 3  months–82  years) and 21 
(43.7  %) were male. Twenty-five (52  %) were diagnosed 
with meningitis at discharge and 23 with encephali-
tis (47.9  %). Pathogens were identified in 14 (29.2  %) of 
48 samples by routine evaluation and 15 (31.2 %) by FA 
ME (see Table  1). Among FA ME results, viral patho-
gens were most commonly detected [EBV (8), HSV2 (3), 
VZV (3), HSV1 (1), Enterovirus (1)], followed by bacte-
rial [S. pneumoniae (2)] and fungal [C. gattii/neoformans 
(1)]. Co-detections were present in six patients (12.5 %); 
EBV was present in all (6) along with VZV (2), HSV1 (1), 
HSV2 (1), C. gattii/neoformans (1), and S. pneumoniae 
(1). In 11 (22.9 %) patients, FA ME identified pathogens 
not previously identified. Routine evaluation evaluations 
identified pathogens in 5 (15.2 %) of 33 FA ME negative 
samples [West Nile virus (WNV) (4), Histoplasma cap-
sulatum (1)].
Discussion
Novel and fast molecular techniques are critical in iden-
tifying etiologies and starting appropriate therapy quickly 
in patients with meningitis. PCR assays to diagnose viral 
central nervous system infections have now become 
standard and have largely replaced viral culture [1, 4]. 
PCR, however, continues to be underutilized [1]. Reasons 
for underutilization are multiple and include variable 
approaches to diagnosis and variable access to such test-
ing. The BioFire FA ME addresses such diagnostic under-
utilization by providing a comprehensive panel testing 
for 15 CNS pathogens simultaneously using a minimal 
amount of CSF with rapid turn-around time (1 h). Shown 
to be an effective alternative for other infections such as 
gastroenteritis [3], and bacteremia [5–8] BioFire’s FA ME 
was approved by the Federal Drug Administration on 
October 8, 2015 with promising results both in the US 
[9] and internationally [10, 11]. This is the second report 
[12] of the FA ME’s performance in the US, highlighting 
the importance of additional WNV and Histoplasmosis 
testing.
The FA ME resulted in pathogen detections not pre-
viously recognized and for which treatment is recom-
mended [13], including VZV (n = 2), HSV (n = 2) and S. 
pneumoniae (n = 1) In one patient with VZV identified 
by FA ME, the routine evaluation did not include VZV 
testing (CSF VZV PCR or VZV IgM/IgG). Similarly, one 
patient with HSV identified by FA ME did not have HSV 
testing included in routine evaluation. In both patients, 
no rash was present. Appropriate laboratory studies for 
VZV and HSV should be ordered in any patient with 
unexplained meningoencephalitis, even if cutaneous 
manifestations are absent [14, 15]. In the patient with S. 
pneumoniae identified by FA ME but not routine evalu-
ation, IV antibiotics were administered prior the LP, 
reducing the likelihood of the rapid antigen testing (RAT) 
and CSF culture being positive.
EBV was the most common virus identified by FA ME 
(n = 8), as the sole organism (n = 2) or in co-infection 
(n = 6). Of the patients with EBV identified by FA ME, 
3 had meningitis and 5 encephalitis. The most common 
pathogens identified in aseptic meningitis (Enterovi-
ruses) [1] and encephalitis (HSV, WNV and Enterovirus) 
[13] do not include EBV so it’s not surprising routine 
evaluation did not include EBV testing (EBV CSF PCR 
or EBV IgM, IgG) for any patient. Complications of EBV 
infection are diverse and include a number of neurologic 
manifestations such as meningitis, meningoencephalitis, 
cerebellitis, cranial neuritis and others. Children with 
EBV encephalitis rarely present with infectious mononu-
cleosis symptoms so this particular virus should be con-
sidered in any child with acute childhood encephalitis, 
irrespective of associated symptoms. In a review of 21 
children with EBV encephalitis, >50 % had other patho-
gens identified either by CSF PCR or serology. Additional 
reports of EBV CNS coinfections have been published 
[16, 17]. The role of EBV in meningoencephalitis is 
unclear, so it is not surprising that conventional testing 
did not include EBV for any patient in this study. Further-
more, the recently FDA cleared FA ME does not include 
EBV due to the difficulty in interpretation.
The FA ME panel was not capable of detecting organ-
isms, such as WNV and Histoplasma, which are not 
included in the panel. Despite WNV being prevalent in 
Texas (the location of 4 enrolling hospitals) [18], only 19 
(39.6 %) were tested for WNV with serology. Similarly, in 
a review of 323 patients with aseptic meningoencephali-
tis, <50 % had WNV serology performed [1]. The addition 
of arboviral serology to routine evaluation [1] (CSF WNV 
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IgM, serum WNV IgM/IgG) during peak summer months 
would improve yield of diagnostic evaluation. Histoplas-
mosis is similarly common in Texas [19], often presenting 
in immunocompromised patients with chronic meningi-
tis [13]. Only one patient in our study was identified to 
have Histoplasmosis (positive urinary Histoplasma anti-
gen test) and was immunocompromised (AIDS). Special 
stains of sputum, blood, CSF as well as CSF antigen, CSF 
Ab test, and fungal culture, none of which were used, can 
also identify H. capsulatum. A fungal stain was not done 
in our patient, only a fungal culture.
Our study had several limitations. First, our study was 
observational so routine evaluation was driven by inde-
pendent physicians (versus a standardized diagnostic 
workup). The variability in diagnostic evaluation resulted 
in incomplete data and hence inability to perform complete 
analysis of the FA ME panel dynamics including sensitiv-
ity and specificity. Secondly, the study involved 4 different 
institutions each with independent laboratories among 
which assays differing in sensitivity could have affected 
patient results. Furthermore, the use of residual CSF might 
lead to a selection bias. And finally, FA ME testing was only 
performed on those patients with additional CSF available, 
which could have resulted in a selection bias.
In conclusion, we compared the performance of stand-
ard evaluation to the BioFire Film Array Meningitis/
Encephalitis panel in 48 patients. The BioFire FA ME 
panel detected organisms that were missed by conven-
tional laboratory studies. The BioFire ME panel cannot 
replace some conventional laboratory studies, because it 
does not test for all organisms responsible for meningitis 
and encephalitis. FA ME offered comprehensive, stand-
ard, rapid testing with minimal use of CSF volume. Rapid, 
comprehensive testing for the most common pathogens 
causing meningitis will aid in the diagnosis and treatment 
of patients with central nervous system infections.
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